Collaboration Target Exclusivity. So long as ImClone or its licensee is proceeding with Due Diligence, CombiChem shall not work on a Collaboration Target with any Third Parties. In the event that ImClone or its licensee fails to exercise Due Diligence with respect to, or notifies CombiChem that it has abandoned work on, any Collaboration Target (an "Abandoned Target") and any Collaboration Compound, other than an ImClone Compound which is subject to the rights of a Third Party licensor, associated with such Collaboration Target (together with all derivatives of such Collaboration Compound, an "Abandoned Compound"), then, (a) such Abandoned Target shall not be subject to any provision hereunder, and (b) such Abandoned Compound shall be available to CombiChem for any purpose thereafter.
Collaboration Target Exclusivity. Prior to designating a Collaboration Target for an active Research Program under Article 3, and thereafter so long as Athena or its Affiliates are proceeding with Due Diligence for that Target, CombiChem shall not knowingly work on or knowingly provide information regarding a Collaboration Target with or to any Third Parties, except (a) as provided for in Section 12.2 with regard to any Public Statements, and (b) with respect to any Third Parties who are collaborators or proposed collaborators of CombiChem, CombiChem shall have the right, consistent with its corporate policy (but without identifying any Collaboration Target), to notify any such Third Party of its decision and/or inability to work on such Target with that Third Party. In the event that Athena or its Affiliates have not transferred or assigned control of its program for that Target to a Third Party under due diligence obligations no less stringent than those set forth herein and have failed to exercise Due Diligence with respect to, or notifies CombiChem in writing that it has abandoned work on, any Collaboration Target (an "Abandoned Target") and any Collaboration Compound associated with such Abandoned Target (together with all Derivatives of such Collaboration Compound, an "Abandoned Compound"), then such Abandoned Target and/or Abandoned Compound shall be available to CombiChem (excluding any Athena Compounds and Athena Technology) and to Athena for any purpose thereafter.
Collaboration Target Exclusivity. (a) Following the Effective Date, so long as ICOS or its Affiliates are proceeding with Due Diligence for that Collaboration Target, CombiChem shall not work on, or provide services, or advise, either independently, or with any Third Parties (except where CombiChem is providing its UIL to Third Parties without knowledge of such Third Parties' target) (the "Target Exclusivity Obligations"), except (a) as provided for in Section 12.2 hereof with regard to any Public Statements, (b) with respect to any Third Parties who are collaborators or proposed collaborators of CombiChem, CombiChem shall have the right, consistent with its corporate policy (but without identifying any Collaboration Target), to notify any such Third Party of its decision and/or inability to work on such Collaboration Target with that Third Party or (c) if CombiChem's Target Exclusivity Obligations have terminated pursuant to subsection 4.1 (b) below.
Collaboration Target Exclusivity. During the Term, Carisma and its Affiliates shall not, either for their own benefit or on behalf of any Third Party (and shall not grant or maintain a grant to any rights to any Third Parties to), research, Develop or Commercialize, any product incorporating or directed to any Collaboration Target, other than in performance of this Agreement, provided that the foregoing shall not apply to the conduct of any Carisma [**] Field Research Program in the [**] Field pursuant to Section 4.1.2(b).
Collaboration Target Exclusivity. Subject to Section 2.7 and Section 3.5 below, during the Exclusivity Period Sunesis shall collaborate exclusively with Biogen Idec with respect to each Collaboration Target and with respect to Target Selective Compounds. Subject to Section 2.7, during the Exclusivity Period Biogen Idec shall collaborate exclusively with Sunesis with respect to each Collaboration Target and with respect to Target Selective Compounds. Notwithstanding the foregoing, neither Party shall be deemed in breach of this Section 2.4 if it engages in activities, or licenses a Third Party, with respect to a compound that does not specifically and directly modulate a Collaboration Target, to the knowledge of such Party at the time such Party engages in such activities or granted such license (or if earlier, at the time such Party first became obligated to engage in such activities or grant such license). It is understood and acknowledged, however, that nothing in the preceding sentence shall be deemed to limit or modify the obligations set forth in Section 6.6 hereof or the licenses granted in Article 6. In addition, it is understood and acknowledged that nothing in this Section 2.4 shall restrict either Party from research, development or commercialization activities with protein or peptide therapeutics directed to Collaboration Targets, either through an internal program or a bona fide collaboration with a Third Party. The term peptide therapeutics in the preceding sentence shall mean peptides having a molecular weight greater than 1,000 daltons.
Collaboration Target Exclusivity. 9 5.2 *** ....................................... 9
Collaboration Target Exclusivity. During the Collaboration Target Exclusivity Period, CCI shall not work on such Collaboration Target with any party other than RBS or its Affiliates; provided, however, that if RBS (i) elects not to continue development of Collaboration Compounds against a Collaboration Target or (ii) ceases to pursue development of any Collaboration Compound with Due Diligence against a Collaboration Target and is not pursuing another Collaboration Compound against the same Collaboration Target, the Collaboration Target Exclusivity Period for such Collaboration Target will terminate and CCI will thereafter be free to work with any Third Party with respect to such Collaboration Target. In addition, following termination of the relevant Collaboration Target Exclusivity Period, CCI shall be free to work with any Third Party on a Collaboration Target.
Collaboration Target Exclusivity. During the Collaboration Target Exclusivity Period, CCI shall not work on such Collaboration Target with any party other than RBS or its Affiliates; provided, however, *** *** *** *** *** *** *** . In addition, following termination of the relevant Collaboration Target Exclusivity Period, CCI shall be free to work with any Third Party on a Collaboration Target.
Collaboration Target Exclusivity. So long as Sumitomo is proceeding with Due Diligence, CombiChem shall not work on a Collaboration Target with any third parties.
Collaboration Target Exclusivity
